European Association for the Study of Diabetes
@easdnews.bsky.social
840 followers 93 following 340 posts
We promote excellence in #diabetes #care through #research, #networking and #education. The European Association for the Study of Diabetes e.V. (EASD) is a membership-based academic non-profit organization. It was founded in 1965, headquartered in Germany
Posts Media Videos Starter Packs
easdnews.bsky.social
📢 EASD will host its 1st Immunology School for Endocrinology: #Immunology in #Type1Diabetes - bridging the science and clinical impact.

📅 26 - 27 March 2026 |📍Vienna, Austria

Open to EASD Members; doctors, researchers/pharmacists in endocrinology/diabetology.

Apply 👉 www.easd.org/education/me...
Promotional graphic for the “1st Immunology School for Endocrinology,” taking place on 26-27 March 2026 in Vienna, Austria. The design features a blue gradient background with white and turquoise text. On the right side, there are images of a gloved hand performing a finger-prick blood test and stylized blue virus-like illustrations. At the bottom, the EASD (European Association for the Study of Diabetes) logo and the website “easd.org” are displayed.
easdnews.bsky.social
👀Today, on #WorldSightDay, we spotlight the link between #diabetes & vision. Diabetic #retinopathy is a leading cause of blindness, yet often preventable with early screening & good diabetes management.

👁 Early action saves. Protect your #vision.

#WSD2025 #DiabetesAwareness #LoveYourEyes
Graphic for World Sight Day 2025 featuring a close-up image of a blue human eye framed by circular design elements in white and blue tones. The text reads: “Diabetic retinopathy is one of the leading causes of vision loss but, if caught early, one of the most preventable.” The EASD (European Association for the Study of Diabetes) logo appears at the bottom left, and the website easd.org is shown on the right. The background transitions from light blue to deep blue.
easdnews.bsky.social
✈️👉 How well does #ditech perform in the air?

Prof. Julia Mader explains how her European Union Aviation Safety Agency-backed project is testing #CGM and #AID at altitude, and why this could reshape aviation rules.

Watch this new #ExpertInsights episode here: easd-elearning.eu/episode/344/...
easdnews.bsky.social
🎓Great Opportunity for #earlycareer #diabetes researchers & clinicians!

The EASD Early Career Academy Mentorship Programme is now open for applications!

Highlights:
✅1-year #mentorship
✅Up to €1,000 travel support p.a.

Apply by 3 Nov 2025, 12:00 CET

Don’t miss this🔗👉 www.easd.org/academy/acad...
Graphic announcing the EASD Early Career Academy Mentorship Programme. Text reads: ‘New Call! EASD Early Career Academy Mentorship Programme – Bringing together junior clinicians and researchers with established mentors in the diabetes field.’ On the right, a circular image shows several people stacking their hands in teamwork. EASD Early Career Academy logo and website link easd.org/academy appear at the bottom.
easdnews.bsky.social
🧠Meet Prof. Claudia Cavelti-Weder, #EFSD Future Leaders Mentorship Grant Recipient.
Her iMAC study reveals immune reprogramming in intestinal macrophages in #obesity, uncovering gut-metabolic links&early bariatric biomarkers.

📖 www.medrxiv.org/content/10.1...

Supported by @astra-zeneca.bsky.social
Graphic introducing the EFSD Recipient Research Portrait featuring Professor Claudia Cavelti-Weder from the University Hospital Zurich. The design uses blue and green geometric shapes, with the EFSD logo and text reading “European Foundation for the Study of Diabetes.” A circular photo shows Professor Cavelti-Weder smiling and wearing glasses and a white coat. Visual summarising Professor Claudia Cavelti-Weder’s research titled “Characterisation of human intestinal macrophages in metabolic disease - iMAC study.” The text explains that her research focuses on immune cells in metabolic disease, particularly intestinal macrophages. She discovered transcriptional reprogramming of intestinal myeloid cells in obesity, which suggests immune dampening in the gut that may explain higher infection risks in people with obesity. The EFSD logo appears at the bottom. Graphic stating that the research is supported by the EFSD Future Leaders Mentorship Programme for Clinical Diabetologists, with support from an unrestricted educational grant from AstraZeneca. The design encourages viewers to “Apply for research grants and fellowships” and includes the EFSD logo and website, europeandiabetesfoundation.org.
easdnews.bsky.social
🗣️ Have your say! The panel is welcoming feedback from the public.

At #EASD2025, the updated EASD-ADA draft #consensusreport on managing #type1diabetes in adults was presented.

Submit your comments by 16 October 2025 at 23:59 ET 👉 professional.diabetes.org/clinical-sup...
easdnews.bsky.social
📢 In case you missed it:
At #EASD2025, Richard Holt & Anne Peters presented the updated @easdnews.bsky.social & @amdiabetesassn.bsky.social consensus on adult #type1diabetes care.
Now open for consultation - review & share feedback via QR code or 👉 professional.diabetes.org/clinical-sup...
#T1D
easdnews.bsky.social
📢 Don’t miss the upcoming EASD #EarlyCareer Academy Webinar! Join Profs. Niklas Mejhert & Mikael Rydén (@ki.se) to see how high-res spatial analyses uncover adipose cell organisation & insights into health & #cardiometabolicdisease.

📅14 Oct |🕛17:00 CEST

Register 🔗👉 us06web.zoom.us/webinar/regi...
easdnews.bsky.social
🗣️ Listen in as EASD President, Prof. Chantal Mathieu discusses the MELD-ATG #Trial results on antithymocyte globulin in 5-25 y/o with #t1d, presented at #EASD2025 in Vienna.

📖Published in @thelancet.com : www.thelancet.com/journals/lan...

🎥Full interview: www.springermedicine.com/type-1-diabe...
springermedicine.com
From #EASD2025 - Prof. Chantal Mathieu shares the results of the MELD-ATG trial demonstrating that a low dose of antithymocyte globulin reduces loss of beta cell function in patients aged 5-25 years old who have a recent diagnosis of stage 3 #T1D.

👉 buff.ly/iYjhL6i

#MedSky #DiabetesSky
easdnews.bsky.social
⏰ Applications closing soon! We’re still hiring for an #ExecutiveAssistant to work with EASD leadership & advance our mission!

✅ Organised, structured, strong communicator - we encourage you to apply!

📅Apply by 9 Oct 2025 👉 www.easd.org/uploads/JobA...

#Hiring #JoinOurTeam #DiabetesResearch
easdnews.bsky.social
🌟We’re #hiring! #ExecutiveAssistant to support EASD leadership & drive our mission forward

✅Organised, structured, strong communicator
📅Coordinate meetings & keep things running smoothly

📩Apply by 9 Oct 2025: www.easd.org/uploads/JobA...

#CareerOpportunity #JoinOurTeam #JobOpportunity
easdnews.bsky.social
💥🎙️ New Episode!!!

Prof. Andrew Hattersley ( @exeter.ac.uk), 57th EASD Claude Bernard #Prize recipient, shares how his work on #genetic forms of diabetes has transformed care worldwide & what’s next for #PrecisionMedicine .

🎧 Listen now: www.easd.org/media-centre...

#Diabetes #Research #podcast
Podcast graphic with EASD logo. A man (Prof. Andrew Hattersley, 2025 Claude Bernard Prize recipient) in glasses and suit speaks into a microphone labelled ‘EASD Live’. Soundwave graphic below with the title ‘Precision diabetes’ on a blue background
easdnews.bsky.social
🥁New #DiabetesPerspectives w. Profs Richard Holt, @janespeight.bsky.social & Michelle Law: Decoding the first-ever EASD guideline on #diabetesdistress🎯 evidence-based strategies for the emotional side of living w. #diabetes presented at #EASD2025.

📺 Watch: bit.ly/46NOrmU

✍️ Comment: bit.ly/46MB8TY
easdnews.bsky.social
Meet Dr. Frank Ning (@ki.se), #EFSD/ #LillyDiabetesInternational Young Investigator Awardee.
His work targets VEGF-B in adipose tissue to combat diabetic cardiomyopathy showing inhibition reduces lipotoxicity, fibrosis & improves heart function in #T2D.

📖👉 pubmed.ncbi.nlm.nih.gov/39689809
Graphic titled "Recipient Research Portrait..." featuring a photo of Dr. Frank Chenfei Ning from Karolinska Institute. EFSD (European Foundation for the Study of Diabetes) logo is shown at the bottom. Graphic with text about Dr. Frank Chenfei Ning’s research: "Targeting vascular endothelial growth factor B in adipose tissue as a strategy in combating diabetic cardiomyopathy." The description explains that his research investigates how targeting VEGF-B in adipose tissue may prevent heart damage in type 2 diabetes by reducing toxic lipid accumulation and fibrosis, offering a promising new treatment approach. EFSD logo displayed at the bottom. Graphic stating "Supported by the EFSD/Lilly Young Investigator Research Award Programme." Additional text: "Apply for research grants and fellowships" with the website europeandiabetesfoundation.org. Circular design elements in blue and green decorate the background.
easdnews.bsky.social
📣 Still open: We're hiring an #ExecutiveAssistant to support EASD leadership.

✅ Are you organised, great communicator and a multitasker? This could be the role for you!

🗓Applications close on 9 Oct 2025

Learn more 👉 www.easd.org/uploads/JobA...

#Diabetes #hiring #JoinOurTeam #jobopportunity
easdnews.bsky.social
🌟We’re #hiring! #ExecutiveAssistant to support EASD leadership & drive our mission forward

✅Organised, structured, strong communicator
📅Coordinate meetings & keep things running smoothly

📩Apply by 9 Oct 2025: www.easd.org/uploads/JobA...

#CareerOpportunity #JoinOurTeam #JobOpportunity
easdnews.bsky.social
🚨 New Journal launched at #EASD2025 in Vienna! Introducing @metabologiajnl.bsky.social - sister journal to @diabetologiajnl.bsky.social, peer-reviewed, open-access, obesity & metabolic health; from basic science to clinical trials, reviews & even negative findings.

Learn more 👉 metabologia.org
easdnews.bsky.social
❤️ Today is #WorldHeartDay!
#Diabetes is a major risk factor for #cardiovasculardisease (CVD).
📚 Our e-Learning course covers #CVD in type 1 & type 2 diabetes - from coronary heart disease to stroke, heart failure & vascular disease.
🔗 Learn more: easd-elearning.eu/course/28/Ca...
#MedicalEducation
Cardiovascular health and diabetes
easd-elearning.eu
easdnews.bsky.social
🎙️The EASDtv podcast is back!

The 11th #[email protected] Diabetes Prize for Excellence recipient,Prof. Gerald Shulman, shares 40 years of groundbreaking research on insulin resistance, mitochondria & therapies that could reshape #diabetes care & beyond.

🎧👉 www.easd.org/media-centre...
Graphic with EASD logo. A man, Prof. Gerald Shulman, in a suit and tie speaks into an EASD TV microphone. Text on the image reads: “Targeting mitochondria to treat diabetes and heart disease.” Soundwave graphics are displayed across the lower half.
easdnews.bsky.social
Missed giving your feedback on the EASD’s first clinical practice guideline at #EASD2025?

📢 Worry not! The EASD’s first evidence-based clinical guideline is still open for consultation!

Share your feedback 👉 www.easd.org/guidelines/s...

#diabetes #diabetescare #ClinicalGuidelines
Graphic with red banner reading “Clinical Guideline.” Title text says: “EASD clinical practice guideline for assessing and managing diabetes distress among adults with type 1 and type 2 diabetes.” Subtext notes: “The draft of EASD’s first evidence-based clinical practice guideline is now open for public review and comment.” Background shows a distressed man holding his head. A QR code appears on the right. Bottom includes EASD logo and name, European Association for the Study of Diabetes.
easdnews.bsky.social
🎉👏 Congratulations to our 2025 EASD Honorary Members!
🔷Dame Stephanie Amiel
🔷Asimina Mitrakou
🔷Jay Skyler
🔷Bernard Zinman
We are honoured to recognise their lifelong contributions to #diabetesresearch, education & services to the #diabetes community.
Please join us in celebrating their achievements🙌
easdnews.bsky.social
❗New therapies developed for the treatment of diabetes also protect heart & kidneys.
At #ESCCongress, an @easdnews.bsky.social & @escardio.bsky.social joint session focused on #cardiovascular outcomes in #diabetes.
Watch & read the wrap up 👉 easd-elearning.eu/news/457/ESC...
#WCCardio #DiabetesCare
easdnews.bsky.social
📢 In case you missed it:
At #EASD2025, Richard Holt & Anne Peters presented the updated @easdnews.bsky.social & @amdiabetesassn.bsky.social consensus on adult #type1diabetes care.
Now open for consultation - review & share feedback via QR code or 👉 professional.diabetes.org/clinical-sup...
#T1D
easdnews.bsky.social
💡Meet Assoc. Prof. Marie Jeansson (@ki.se), #EFSD/ @boehringerglobal.bsky.social Awardee. Her work targets angiopoietin-2 & endothelial dysfunction in diabetes complications, testing a TIE2-activating antibody to protect vascular & organ health.

📖: ki.se/en/people/ma...

Explore EFSD opportunities👇
Graphic introducing EFSD Recipient Research Portrait. A portrait photo of Associate Professor Marie Jeansson from Karolinska Institute, Stockholm, is shown within a circular frame. Text reads: “Recipient Research Portrait… Associate Professor Marie Jeansson, Karolinska Institute, Stockholm.” EFSD logo appears at the bottom. Graphic titled: “A novel TIE2 activating treatment to alleviate diabetic complications in kidney, heart, and eye.” Text explains: “Marie Jeansson explores how angiopoietins, particularly angiopoietin-2, contribute to endothelial dysfunction in diabetic complications. She evaluates a novel TIE2-activating antibody for its therapeutic potential in protecting vascular and organ health in diabetic complications.” EFSD logo at the bottom. Graphic with text: “Supported by the EFSD/Boehringer Ingelheim European Research Programme on ‘Multi-System Challenges in Diabetes.’ Apply for research grants and fellowships. europeandiabetesfoundation.org.”
easdnews.bsky.social
🌟We’re #hiring! #ExecutiveAssistant to support EASD leadership & drive our mission forward

✅Organised, structured, strong communicator
📅Coordinate meetings & keep things running smoothly

📩Apply by 9 Oct 2025: www.easd.org/uploads/JobA...

#CareerOpportunity #JoinOurTeam #JobOpportunity
easdnews.bsky.social
⚠️ The @ema.europa.eu & Heads of Medicines Agencies (HMA) warn of a surge in illegal GLP-1 products (e.g. semaglutide, liraglutide, tirzepatide) sold online for weight-loss / #diabetes.

These pose serious health risks. GLP-1s are prescription-only!

More details 👉 www.ema.europa.eu/en/news/warn...
easdnews.bsky.social
📜 From today, you can download your #EASD2025 Certificate of Attendance via your MyEASD account.

A few important reminders:
✅Survey completion required
✅Attendance checked (in person & online)

More info 👉 www.easd.org/annual-meeti...

#CertificateofAttendance #Diabetes #AnnualMeeting
Red graphic for the 61st EASD Annual Meeting, 15-19 September 2025, Vienna, Austria. A blue circle reads ‘Now available’. Main text: ‘Certificate of Attendance - EASD 2025 participants can now download their Certificate of Attendance’. EASD logo and website easd.org appear at the bottom